WELMATE - Urinary Pain Relief (72 Tablets) - Phenazopyridine Hydrochloride 99.5mg - Urinary Pain, Urgency, & Discomfort - Maximum Strength - Over-The-Counter Medication
- Fast Acting Urinary Tract Relief – Phenazopyridine Hydrochloride 99.5mg is the #1 doctor and pharmacist-recommended OTC ingredient for UTI pain, specifically for urinary discomfort.
- Maximum Strength – Delivers the same active ingredient and dosage as AZO Urinary Pain Relief, 99.5mg Phenazopyridine Hydrochloride. Includes 72 tablets.
- Quick Relief & Support – Immediately targets the site of discomfort, soothing the urinary tract, and providing relief within minutes. Symptoms can be caused by injury, surgery, a catheter, or irritation of the bladder.
- How to Use – Adults & Children (12yrs & older), take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. DO NOT use for more than 2 days (12 tablets) without consulting a doctor.
- Why WELMATE? - Founded in 2020 by former pharmacy employees who were fed up with the pricing of over-the-counter medication. Today, we continue to bring affordable health and wellness products to your doorstep as America's trusted OTC store.
Svarīga informācija
Sastāvdaļas
Fenazopiridīna hidrohlorīds 99, 5 mg
Virzieni
Adults and children 12 years and older take 2 tablets 3 times daily with or after eals as needed for up to two days take with a full glass of water do not use for more than 2 days without consulting a doctor children under 12 do not use without consulting a doctor
Juridiska atruna
Paziņojumi par uztura bagātinātājiem nav novērtēta FDA un nav paredzēti, lai diagnosticētu, ārstētu, izārstēt, vai novērstu jebkuru slimību vai veselības stāvokli.
Specifications
| Zīmols | Velmēts |
| Derīguma termiņš | Okt 2027. |
| Vienības svars | 0,09 G |
| Produkta ieguvumi | Uti Relief |
| Īpaši produkta izmantošanas veidi | Sāpes |
| Aktīvās sastāvdaļas | Fenazopiridīns |
| Produkta veids | Zāles |
| Sastāvdaļas | 5 Mg |
| Tags | |
|---|---|
| Tags | |
Jūsu dinamiskais fragments tiks parādīts šeit...
Šis ziņojums tiek parādīts, jo neesat norādījis ne filtru, ne veidni, ko izmantot.